Antibacterial Therapeutics Market: Analysis of strategic consolidations and deals revealed a high level of activity between 2006 and 2017

This report examines the entire antibacterial therapy area with a particular focus on four key indications, methicillin resistant staphylococcus aureus (MRSA), sepsis, pneumonia and tuberculosis, which were selected due to their pipeline size, prevalence and level of unmet need.

Pune, India - March 14, 2018 /MarketersMedia/ —

Antibacterial resistance is currently believed to be responsible for over 700,000 deaths each year. As antibiotic resistance increases, due to the overuse and misuse of antibiotics, the number of avoidable deaths is expected to increase, with one study predicting there will be 10 million deaths caused by bacteria resistant to antibiotics in 2050. There are several techniques being utilized to combat the spread of antibiotic resistance, which range from combining antibiotics to increase efficacy to reducing the use antibiotics in both humans and livestock.
Access Report Details at: https://www.themarketreports.com/report/antibacterial-therapeutics-high-levels-of-pipeline-innovation-focused-on-the-increasing-unmet-need-associated-with-antibiotic-resistance
Scope
• The antibacterial pipeline is large, with 1,634 products in active development. Does current pipeline innovation hold the potential to affect the future antibacterial market?
• The four key indications in the antibacterial pipeline are tuberculosis, pneumonia, MRSA and sepsis. How does the composition of each pipeline compare both in terms of first-in-class and non-first-in-class innovation.
• There are 234 first-in-class products in the antibacterial pipeline. Which of these possess the greatest potential to improve disease outcome and be commercially successful, based on their target?
• Analysis of strategic consolidations and deals revealed a high level of activity between 2006 and 2017.
• A significant number of first-in-class products have been identified with no prior involvement in deals. How does deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935564
Without the development of innovate antibacterial products the emergence and spread of antibiotic resistance will not only increase the number of avoidable deaths caused by the infection itself, it also has the potential to increase the risks associated with surgery, while putting additional pressure on already stretched healthcare providers, as treating drug-resistant infections is considerably more expensive than treating drug-susceptible infections.
Get this report at: https://www.themarketreports.com/report/buy-now/935564

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/antibacterial-therapeutics-market-analysis-of-strategic-consolidations-and-deals-revealed-a-high-level-of-activity-between-2006-and-2017/314320

For more information, please visit https://www.themarketreports.com/report/antibacterial-therapeutics-high-levels-of-pipeline-innovation-focused-on-the-increasing-unmet-need-associated-with-antibiotic-resistance%20

Source: MarketersMedia

Release ID: 314320

More News From Daily Xtreme

Kerevi back for Wallabies, 3 uncapped players also in squad

Oct 19, 2018

SYDNEY — Center Samu Kerevi has been recalled and three uncapped players have been included in Australia's 31-man squad for the third Bledisloe Cup test against New Zealand in Japan on Oct. 27. Wallabies coach Michael Cheika announced the squad on Thursday, giving Waratahs forward Jed Holloway, scrumhalf Jake Gordon and Melbourne Rebels blindside flanker Angus Cottrell a chance to push for test selection. Kerevi, who missed the Rugby Championship with a biceps injury, hasn't played since the third test against Ireland in June. Reece Hodge, who started in the centers for the Wallabies in all six tests in Kerevi's...

New Zealand All Blacks select 51 for season-ending tour

Oct 19, 2018

WELLINGTON, New Zealand — The All Blacks have taken the unprecedented step of selecting a player based in Japan among an enlarged squad of 51 for autumn test matches against Australia, Japan, England, Ireland and Italy. Flanker Matt Todd, who is playing for the Panasonic Wild Knights in Japan's top domestic competition, has been picked for the European section of New Zealand's tour in the absence of Sam Cane, who is convalescing after fracturing his neck. Todd is set to return to New Zealand next year in time to play for the Christchurch-based Crusaders in Super Rugby but would normally...

Australian Grand Prix to lead off F1 2019 schedule

Oct 19, 2018

MELBOURNE, Australia — The Australian Grand Prix has taken its usual place at the top of the calendar for the 2019 Formula One season, with Melbourne to host the opening race on March 17 at Albert Park. World governing body FIA said following a meeting of its World Motor Sport Council on Friday that 21 races will be held next year, with 11 in Europe, five in Asia, four in the Americas and one in Australia. ___ Dates, races and venues for 2019: March 17: Australia, Melbourne March 31: Bahrain, Sakhir April 14: China, Shanghai April 28: Azerbaijan, Baku May...

East to west, Rugby Australia switches venue for Bledisloe

Oct 19, 2018

PERTH, Australia — Rugby Australia is moving one of the Bledisloe Cup tests west to Perth next year, hoping that a change from the traditional venues will bring about a change in the Wallabies' fortunes against a dominant New Zealand in the annual series. The All Blacks have held the Bledisloe Cup since 2003 and clinched this year's series with wins in the first two matches in Sydney and Auckland. A third match is to be played on neutral ground in Yokohama, Japan, on Oct. 27. Rugby Australia on Thursday said the Western Australia match would be held on Aug....

All Blacks experiment against Argentina ahead of World Cup

Oct 19, 2018

WELLINGTON, New Zealand — All Blacks coach Steve Hansen says Saturday's Rugby Championship test against Argentina in Buenos Aires is part of a two-match experiment, imperative to New Zealand's defense of the World Cup in Japan next year. Hansen said the All Blacks' last two matches against Argentina and South Africa will allow coaches and players to simulate conditions New Zealand might encounter in the knockout stages of a World Cup. He said if New Zealand reaches the playoff stages of the world tournament it will have to win two "big" matches to reach the final. Its next two tests...

NHL Livescore